Lantern Pharma, Inc. (LTRN)
0.6354
-0.01
(-0.83%)
USD |
NASDAQ |
Oct 23, 16:00
0.622
-0.01
(-2.11%)
After-Hours: 20:00
Lantern Pharma Net Income (Quarterly) : -7.072M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.072M |
| March 31, 2026 | -3.329M |
| December 31, 2025 | -4.074M |
| September 30, 2025 | -4.177M |
| June 30, 2025 | -4.331M |
| March 31, 2025 | -4.537M |
| December 31, 2024 | -5.875M |
| September 30, 2024 | -4.506M |
| June 30, 2024 | -4.960M |
| March 31, 2024 | -5.441M |
| December 31, 2023 | -4.186M |
| September 30, 2023 | -3.161M |
| June 30, 2023 | -4.746M |
| March 31, 2023 | -3.868M |
| Date | Value |
|---|---|
| December 31, 2022 | -3.381M |
| September 30, 2022 | -2.265M |
| June 30, 2022 | -4.492M |
| March 31, 2022 | -4.122M |
| December 31, 2021 | -3.540M |
| September 30, 2021 | -4.054M |
| June 30, 2021 | -2.316M |
| March 31, 2021 | -2.452M |
| December 31, 2020 | -2.896M |
| September 30, 2020 | -1.702M |
| June 30, 2020 | -0.8334M |
| March 31, 2020 | -0.4773M |
| June 30, 2019 | -0.6294M |
| March 31, 2019 | -0.454M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 7.072M |
| EPS Diluted (Quarterly) | -0.5693 |
| Enterprise Value | 0.7855M |
| Earnings Yield | -253.8% |
| Normalized Earnings Yield | -234.95 |